cjrABC-senB hinders survival of extraintestinal pathogenic E. coli in the bloodstream through triggering complement-mediated killing.
Bacteremia
ExPEC
Extraintestinal pathogenic E. coli
Urinary tract infections
cjrA
cjrABC-senB
cjrB
cjrC
senB
Journal
Journal of biomedical science
ISSN: 1423-0127
Titre abrégé: J Biomed Sci
Pays: England
ID NLM: 9421567
Informations de publication
Date de publication:
06 Aug 2020
06 Aug 2020
Historique:
received:
27
10
2019
accepted:
28
07
2020
entrez:
9
8
2020
pubmed:
9
8
2020
medline:
23
3
2021
Statut:
epublish
Résumé
Extraintestinal pathogenic E. coli (ExPEC) is a common gram-negative organism causing various infections, including urinary tract infections (UTIs), bacteremia, and neonatal meningitis. The cjrABC-senB gene cluster of E. coli contributes to ExPEC virulence in the mouse model of UTIs. Consistently, the distribution of cjrABC-senB is epidemiologically associated with human UTIs caused by E. coli. cjrABC-senB, which has previously been proposed to encode an iron uptake system, may facilitate ExPEC survival in the iron availability-restricted urinary tract. Given that the bloodstream is also an iron limited environment to invading bacteria, the pathogenic role of cjrABC-senB in ExPEC bacteremia, however, remains to be investigated. The ability of ExPEC RS218 strains with and without cjrABC-senB to survive in the mouse bloodstream and human serum was evaluated. Subsequently, the role of this gene cluster in the ExPEC interaction with the complement system was evaluated. Finally, the distribution of cjrABC-senB in human clinical E. coli isolates was determined by PCR. The frequency of cjrABC-senB in bacteremia isolates that were not associated with UTIs (non-UTI bacteremia isolates) was compared with that in UTI-associated isolates and fecal isolates. Expression of cjrABC-senB attenuated the survival of RS218 in the mouse bloodstream and human serum. The cjrABC-senB-harboring strains triggered enhanced classical- and alternative-complement pathway activation and became more vulnerable to complement-mediated killing in serum. cjrA was identified as the major gene responsible for the attenuated serum survival. Expressing cjrABC-senB and cjrA increased bacterial susceptibility to detergent and induced periplasmic protein leakage, suggesting that the expression of these genes compromises the integrity of the outer membrane of ExPEC. In addition, the frequency of cjrABC-senB in non-UTI bacteremia isolates was significantly lower than that in UTI-associated isolates, while the frequencies in non-UTI bacteremia isolates and fecal isolates showed no significant difference. Consistently, this epidemiological investigation suggests that cjrABC-senB does not contribute to E. coli bacteremia in humans. The contribution of cjrABC-senB to the pathogenesis of ExPEC is niche dependent and contradictory because the genes facilitate ExPEC UTIs but hinder bacteremia. The contradictory niche-dependent characteristic may benefit the development of novel strategies against E. coli-caused infections.
Sections du résumé
BACKGROUND
BACKGROUND
Extraintestinal pathogenic E. coli (ExPEC) is a common gram-negative organism causing various infections, including urinary tract infections (UTIs), bacteremia, and neonatal meningitis. The cjrABC-senB gene cluster of E. coli contributes to ExPEC virulence in the mouse model of UTIs. Consistently, the distribution of cjrABC-senB is epidemiologically associated with human UTIs caused by E. coli. cjrABC-senB, which has previously been proposed to encode an iron uptake system, may facilitate ExPEC survival in the iron availability-restricted urinary tract. Given that the bloodstream is also an iron limited environment to invading bacteria, the pathogenic role of cjrABC-senB in ExPEC bacteremia, however, remains to be investigated.
METHODS
METHODS
The ability of ExPEC RS218 strains with and without cjrABC-senB to survive in the mouse bloodstream and human serum was evaluated. Subsequently, the role of this gene cluster in the ExPEC interaction with the complement system was evaluated. Finally, the distribution of cjrABC-senB in human clinical E. coli isolates was determined by PCR. The frequency of cjrABC-senB in bacteremia isolates that were not associated with UTIs (non-UTI bacteremia isolates) was compared with that in UTI-associated isolates and fecal isolates.
RESULTS
RESULTS
Expression of cjrABC-senB attenuated the survival of RS218 in the mouse bloodstream and human serum. The cjrABC-senB-harboring strains triggered enhanced classical- and alternative-complement pathway activation and became more vulnerable to complement-mediated killing in serum. cjrA was identified as the major gene responsible for the attenuated serum survival. Expressing cjrABC-senB and cjrA increased bacterial susceptibility to detergent and induced periplasmic protein leakage, suggesting that the expression of these genes compromises the integrity of the outer membrane of ExPEC. In addition, the frequency of cjrABC-senB in non-UTI bacteremia isolates was significantly lower than that in UTI-associated isolates, while the frequencies in non-UTI bacteremia isolates and fecal isolates showed no significant difference. Consistently, this epidemiological investigation suggests that cjrABC-senB does not contribute to E. coli bacteremia in humans.
CONCLUSION
CONCLUSIONS
The contribution of cjrABC-senB to the pathogenesis of ExPEC is niche dependent and contradictory because the genes facilitate ExPEC UTIs but hinder bacteremia. The contradictory niche-dependent characteristic may benefit the development of novel strategies against E. coli-caused infections.
Identifiants
pubmed: 32762693
doi: 10.1186/s12929-020-00677-4
pii: 10.1186/s12929-020-00677-4
pmc: PMC7412671
doi:
Substances chimiques
Escherichia coli Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
86Subventions
Organisme : Ministry of Science and Technology, Taiwan
ID : 108-2320-B-006-034-MY3
Organisme : Ministry of Science and Technology, Taiwan
ID : MOST 104-2320-B-006-003
Organisme : Ministry of Science and Technology, Taiwan
ID : NSC 102-2628-B-006-004-MY3
Organisme : National Cheng Kung University Hospital
ID : NCKUH-10301001
Références
Infect Immun. 1983 Jan;39(1):315-35
pubmed: 6218094
Mol Immunol. 2014 Nov;62(1):104-13
pubmed: 24980869
Immunol Rev. 2016 Nov;274(1):172-190
pubmed: 27782331
Mol Immunol. 2000 Oct;37(14):803-11
pubmed: 11257302
PLoS Pathog. 2009 Feb;5(2):e1000305
pubmed: 19229321
FEMS Microbiol Lett. 2014 May;354(1):1-9
pubmed: 24617921
Infect Immun. 2000 Dec;68(12):6744-9
pubmed: 11083790
J Immunol. 1981 Sep;127(3):1146-51
pubmed: 6267132
J Vis Exp. 2010 Mar 29;(37):
pubmed: 20351687
J Clin Microbiol. 2012 Feb;50(2):449-56
pubmed: 22075599
Nat Med. 2001 Jul;7(7):801-6
pubmed: 11433344
Genome Announc. 2015 Feb 26;3(1):
pubmed: 25720688
BMC Microbiol. 2014 Aug 28;14:203
pubmed: 25164788
Infect Immun. 1991 Jul;59(7):2252-8
pubmed: 1646768
PLoS Pathog. 2010 Aug 12;6(8):e1000949
pubmed: 20711357
Nucleic Acids Res. 1989 Apr 25;17(8):3318
pubmed: 2498840
Infect Immun. 2010 Apr;78(4):1457-67
pubmed: 20123719
Kidney Int. 1993 Jul;44(1):50-7
pubmed: 8355466
Infect Immun. 1980 Jul;29(1):200-6
pubmed: 6995336
Infect Immun. 2009 Dec;77(12):5322-33
pubmed: 19797063
Microbiol Mol Biol Rev. 2007 Mar;71(1):158-229
pubmed: 17347522
Infect Immun. 2010 Jul;78(7):3090-6
pubmed: 20421385
Avian Dis. 2002 Jul-Sep;46(3):668-78
pubmed: 12243531
Int J Biochem Cell Biol. 2001 Oct;33(10):940-59
pubmed: 11470229
Mol Immunol. 2008 Feb;45(4):954-62
pubmed: 17870166
J Immunol. 2007 Aug 15;179(4):2600-8
pubmed: 17675523
N Engl J Med. 2001 Apr 5;344(14):1058-66
pubmed: 11287977
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
pubmed: 10829079
PLoS One. 2017 Dec 13;12(12):e0189032
pubmed: 29236742
J Immunol. 2006 Aug 15;177(4):2543-51
pubmed: 16888016
Cell Microbiol. 2019 Oct;21(10):e13085
pubmed: 31290210
J Biomed Sci. 2020 Jan 3;27(1):14
pubmed: 31900139
Mol Immunol. 2000 Apr;37(5):191-201
pubmed: 10930626
Infect Immun. 1983 Dec;42(3):907-13
pubmed: 6196296
Infect Immun. 2012 Jul;80(7):2538-47
pubmed: 22508857
J Bacteriol. 1981 Mar;145(3):1351-8
pubmed: 7009581
Foodborne Pathog Dis. 2013 Nov;10(11):916-32
pubmed: 23962019
Can J Microbiol. 1984 May;30(5):711-3
pubmed: 6744128
FEMS Microbiol Lett. 2009 Sep;298(1):1-11
pubmed: 19519769
J Bacteriol. 2001 Jul;183(13):3958-66
pubmed: 11395459
Trends Microbiol. 2005 Jun;13(6):246-8
pubmed: 15936653
Expert Rev Anti Infect Ther. 2012 Oct;10(10):1165-76
pubmed: 23199402
Microb Pathog. 2016 Sep;98:57-62
pubmed: 27364548
Gut Microbes. 2013 Jul-Aug;4(4):271-80
pubmed: 23651955
Infect Immun. 2012 Oct;80(10):3669-78
pubmed: 22802341
J Immunol. 1990 Nov 15;145(10):3367-71
pubmed: 2230122
Mol Microbiol. 1991 May;5(5):1005-11
pubmed: 1683466
J Clin Invest. 1991 Aug;88(2):379-84
pubmed: 1864952
J Immunol. 2002 Dec 1;169(11):6352-60
pubmed: 12444142
Nucleic Acids Res. 1990 Aug 11;18(15):4631
pubmed: 2201955
Appl Environ Microbiol. 2002 Aug;68(8):4117-21
pubmed: 12147516
Infect Immun. 2012 Oct;80(10):3399-409
pubmed: 22825444
Nephron. 1998;78(1):15-22
pubmed: 9453398
Front Cell Infect Microbiol. 2013 Oct 02;3:59
pubmed: 24106689
J Mol Biol. 2006 Oct 6;362(5):1108-19
pubmed: 16950397
J Bacteriol. 1973 Sep;115(3):717-22
pubmed: 4580564
Kidney Int. 2018 Dec;94(6):1141-1150
pubmed: 30322716